Innovative Partnership in Blood Health Education
Velico, a pioneer in the development of spray dried plasma technology, proudly announces an exciting collaboration with Versiti, Inc., a leader in blood health innovation. Together, they are launching the Blood Center Education Program (BCEP) aimed at transforming operational practices in blood centers.
Goals of the Blood Center Education Program
The BCEP is designed to offer valuable, hands-on training for partner blood centers. Participants will get to experience Velico's cutting-edge FrontlineODP™ system, which facilitates the spray drying of plasma. This unique program will enable healthcare facilities to assess the technology's compatibility with their needs while providing them critical feedback to optimize utilization.
Enhancing Plasma Availability
The FrontlineODP™ system embodies innovative technology that brings forth numerous advantages in emergency medical situations. By ensuring plasma is readily available when needed most, this integration stands to revolutionize storage and distribution processes. Key benefits include rapid rehydration, extended shelf life, ease of transport, and minimal wastage, which are crucial in urgent scenarios.
Shared Commitment to Life-Saving Innovations
Richard Meehan, President and CEO of Velico, emphasizes the importance of this collaboration, noting, "Our partnership embodies our mutual commitment to saving lives through innovative blood products." This synergy between the two organizations underscores their dedication to improving patient outcomes in critical settings.
Versiti's Longstanding Legacy in Transfusion Medicine
Versiti has played a vital role in advancing transfusion medicine since its inception in 1947. Dr. Barbara Bryant, executive vice president and Chief Medical Officer at Versiti, articulates the organization's mission to continually advance technologies related to blood. The BCEP offers a distinctive opportunity to engage with pioneering advancements that promise to enhance services provided to prehospital care providers in future scenarios.
Funding and Development Background
Velico's endeavors to develop the FrontlineODP™ system have been bolstered by federal support from the Department of Health and Human Services and associated authorities. Such backing is essential for pushing forward innovative medical technologies focused on reducing preventable deaths from bleeding.
About Velico and Its Vision
Velico, Inc., a private medical technology company based in Massachusetts, is dedicated to its mission of preventing unnecessary deaths caused by bleeding. Their team comprises individuals with extensive knowledge and experience in transfusion medicine and medical device advancement. Velico is actively collaborating with blood center leaders, trauma specialists, and emergency medical professionals globally.
About Versiti and Its Impact
Versiti, Inc. is recognized as a national leader in blood health solutions, striving to enhance patient health and support healthcare partners with innovative approaches in transfusion medicine and related fields. Their constant focus on research and development enables significant improvements in patient outcomes and system efficiency across healthcare networks.
Frequently Asked Questions
What is the purpose of the Blood Center Education Program?
The BCEP aims to provide blood centers with hands-on training on Velico's FrontlineODP™ system, enhancing their ability to use spray dried plasma in emergency situations.
How does the FrontlineODP™ system benefit medical emergencies?
This innovative system ensures quick rehydration of plasma, extends its shelf life, and minimizes wastage, making it essential in critical medical scenarios.
Who is involved in this collaboration?
The partnership involves Velico, a developer of plasma technology, and Versiti, a leader in blood health innovations.
What recognition does Versiti have in the medical community?
Versiti has been instrumental in the field of transfusion medicine since 1947, continually advancing research and technologies for better patient care.
How is Velico funded for its development projects?
Velico's projects receive partial funding from the Department of Health and Human Services to support innovation in blood health technologies.
